Global Nuclear Medicine/Radiopharmaceuticals Market Professional Survey Report 2018

Publisher : XYZResearch Publication Date : Jun 12, 2018

Number of Pages : 102 Subcategory : Pharmaceuticals
Single User $ 2800
Global User $ 5500

Want to have a look at sample?

Request sample

Want to check today's discount?

Enquiry for Discount
  • Description

    Product Description

    This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
    Cardinal Health
    Mallinckrodt
    GE Healthcare
    Lantheus Medical Imaging
    Bayer
    Bracco Imaging
    Eczacibasi-Monrol Nuclear Products
    Nordion
    Advanced Accelerator Applications
    IBA Molecular Imaging

    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Diagnostic (SPECT - Technetium, PET - F-18)
    Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90)

    By Application, the market can be split into
    Oncology
    Thyroid
    Cardiology

    By Regions, this report covers (we can add the regions/countries as you want)
    North America
    Europe
    China
    Japan
    Southeast Asia
    India

    If you have any special requirements, please let us know and we will offer you the report as you want.

  • Table of Content

    Global Nuclear Medicine/Radiopharmaceuticals Market Professional Survey Report 2018

    Table of Contents

    Global Nuclear Medicine/Radiopharmaceuticals Market Professional Survey Report 2017
    1 Industry Overview of Nuclear Medicine/Radiopharmaceuticals
    1.1 Definition and Specifications of Nuclear Medicine/Radiopharmaceuticals
    1.1.1 Definition of Nuclear Medicine/Radiopharmaceuticals
    1.1.2 Specifications of Nuclear Medicine/Radiopharmaceuticals
    1.2 Classification of Nuclear Medicine/Radiopharmaceuticals
    1.2.1 Global Nuclear Medicine/Radiopharmaceuticals Production (K Units) and Growth Rate (%) Comparison by Types (2012-2023)
    1.2.2 Global Nuclear Medicine/Radiopharmaceuticals Production Market Share (%) by Types in 2017
    1.2.3 Diagnostic (SPECT - Technetium, PET - F-18)
    1.2.4 Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90)
    1.3 Applications of Nuclear Medicine/Radiopharmaceuticals
    1.3.1 Global Nuclear Medicine/Radiopharmaceuticals Consumption (K Units) Comparison by Applications (2012-2023)
    1.3.2 Oncology
    1.3.3 Thyroid
    1.3.4 Cardiology
    1.4 Global Nuclear Medicine/RadiopharmaceuticalsMarket by Regions (2012-2023)
    1.4.1 Global Nuclear Medicine/Radiopharmaceuticals Market Size and Growth Rate (%) Comparison by Regions (2012-2023)
    1.4.2 North AmericaNuclear Medicine/Radiopharmaceuticals Status and Prospect (2012-2023)
    1.4.3 EuropeNuclear Medicine/Radiopharmaceuticals Status and Prospect (2012-2023)
    1.4.4 ChinaNuclear Medicine/Radiopharmaceuticals Status and Prospect (2012-2023)
    1.4.5 JapanNuclear Medicine/Radiopharmaceuticals Status and Prospect (2012-2023)
    1.4.6 Southeast AsiaNuclear Medicine/Radiopharmaceuticals Status and Prospect (2012-2023)
    1.5 Global Nuclear Medicine/Radiopharmaceuticals Market Size (2012-2023)
    1.5.1 Global Nuclear Medicine/Radiopharmaceuticals Revenue (Million USD) Status and Outlook (2012-2023)
    1.5.2 Global Nuclear Medicine/Radiopharmaceuticals Capacity, Production (K Units) Status and Outlook (2012-2023)

    2 Industrial Chain Analysis
    2.1 Industry Chain Structure of Nuclear Medicine/Radiopharmaceuticals
    2.2 Raw Material Analysis of Nuclear Medicine/Radiopharmaceuticals
    2.2.1 Raw Material A Market Analysis
    2.2.2 Raw Material B Market Analysis
    2.2.3 Raw Material C Market Analysis
    2.3 Labor Cost Analysis of Nuclear Medicine/Radiopharmaceuticals
    2.4 Other Costs Analysis of Nuclear Medicine/Radiopharmaceuticals
    2.5 Manufacturing Cost Structure Analysis of Nuclear Medicine/Radiopharmaceuticals
    2.6 Manufacturing Process Analysis of Nuclear Medicine/Radiopharmaceuticals
    2.7 Raw Materials Sources of Nuclear Medicine/Radiopharmaceuticals Major Manufacturers in 2017
    2.8 Downstream Buyers of Nuclear Medicine/Radiopharmaceuticals

    3 Global Nuclear Medicine/Radiopharmaceuticals Manufacturers Profiles/Analysis
    3.1 Cardinal Health
    3.1.1 Company Basic Information, Manufacturing Base and Competitors
    3.1.2 Nuclear Medicine/Radiopharmaceuticals Product Category, Application and Specification
    3.1.2.1 Diagnostic (SPECT - Technetium, PET - F-18)
    3.1.2.2 Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90)
    3.1.3 Cardinal Health 2017 Nuclear Medicine/Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
    3.1.4 Cardinal Health 2017 Business Region Distribution Analysis
    3.1.5 Cardinal Health Nuclear Medicine/Radiopharmaceuticals Volume in Different Applications and Its Application Share
    3.2 Mallinckrodt
    3.2.1 Company Basic Information, Manufacturing Base and Competitors
    3.2.2 Nuclear Medicine/Radiopharmaceuticals Product Category, Application and Specification
    3.2.2.1 Diagnostic (SPECT - Technetium, PET - F-18)
    3.2.2.2 Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90)
    3.2.3 Mallinckrodt 2017 Nuclear Medicine/Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
    3.2.4 Mallinckrodt 2017 Business Region Distribution Analysis
    3.2.5 Mallinckrodt Nuclear Medicine/Radiopharmaceuticals Volume in Different Applications and Its Application Share
    3.3 GE Healthcare
    3.3.1 Company Basic Information, Manufacturing Base and Competitors
    3.3.2 Nuclear Medicine/Radiopharmaceuticals Product Category, Application and Specification
    3.3.2.1 Diagnostic (SPECT - Technetium, PET - F-18)
    3.3.2.2 Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90)
    3.3.3 GE Healthcare 2017 Nuclear Medicine/Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
    3.3.4 GE Healthcare 2017 Business Region Distribution Analysis
    3.3.5 GE Healthcare Nuclear Medicine/Radiopharmaceuticals Volume in Different Applications and Its Application Share
    3.4 Lantheus Medical Imaging
    3.4.1 Company Basic Information, Manufacturing Base and Competitors
    3.4.2 Nuclear Medicine/Radiopharmaceuticals Product Category, Application and Specification
    3.4.2.1 Diagnostic (SPECT - Technetium, PET - F-18)
    3.4.2.2 Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90)
    3.4.3 Lantheus Medical Imaging 2017 Nuclear Medicine/Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
    3.4.4 Lantheus Medical Imaging 2017 Business Region Distribution Analysis
    3.4.5 Lantheus Medical Imaging Nuclear Medicine/Radiopharmaceuticals Volume in Different Applications and Its Application Share
    3.5 Bayer
    3.5.1 Company Basic Information, Manufacturing Base and Competitors
    3.5.2 Nuclear Medicine/Radiopharmaceuticals Product Category, Application and Specification
    3.5.2.1 Diagnostic (SPECT - Technetium, PET - F-18)
    3.5.2.2 Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90)
    3.5.3 Bayer 2017 Nuclear Medicine/Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
    3.5.4 Bayer 2017 Business Region Distribution Analysis
    3.5.5 Bayer Nuclear Medicine/Radiopharmaceuticals Volume in Different Applications and Its Application Share
    3.6 Bracco Imaging
    3.6.1 Company Basic Information, Manufacturing Base and Competitors
    3.6.2 Nuclear Medicine/Radiopharmaceuticals Product Category, Application and Specification
    3.6.2.1 Diagnostic (SPECT - Technetium, PET - F-18)
    3.6.2.2 Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90)
    3.6.3 Bracco Imaging Nuclear Medicine/Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
    3.6.4 Bracco Imaging 2017 Business Region Distribution Analysis
    3.6.5 Bracco Imaging Nuclear Medicine/Radiopharmaceuticals Volume in Different Applications and Its Application Share
    3.7 Eczacibasi-Monrol Nuclear Products
    3.7.1 Company Basic Information, Manufacturing Base and Competitors
    3.7.2 Nuclear Medicine/Radiopharmaceuticals Product Category, Application and Specification
    3.7.2.1 Diagnostic (SPECT - Technetium, PET - F-18)
    3.7.2.2 Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90)
    3.7.3 Eczacibasi-Monrol Nuclear Products 2017 Nuclear Medicine/Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
    3.7.4 Eczacibasi-Monrol Nuclear Products 2017 Business Region Distribution Analysis
    3.7.5 Eczacibasi-Monrol Nuclear Products Nuclear Medicine/Radiopharmaceuticals Volume in Different Applications and Its Application Share
    3.8 Nordion
    3.8.1 Company Basic Information, Manufacturing Base and Competitors
    3.8.2 Nuclear Medicine/Radiopharmaceuticals Product Category, Application and Specification
    3.8.2.1 Diagnostic (SPECT - Technetium, PET - F-18)
    3.8.2.2 Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90)
    3.8.3 Nordion 2017 Nuclear Medicine/Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
    3.8.4 Nordion 2017 Business Region Distribution Analysis
    3.8.5 Nordion Nuclear Medicine/Radiopharmaceuticals Volume in Different Applications and Its Application Share
    3.9 Advanced Accelerator Applications
    3.9.1 Company Basic Information, Manufacturing Base and Competitors
    3.9.2 Nuclear Medicine/Radiopharmaceuticals Product Category, Application and Specification
    3.9.2.1 Diagnostic (SPECT - Technetium, PET - F-18)
    3.9.2.2 Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90)
    3.9.3 Advanced Accelerator Applications 2017 Nuclear Medicine/Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
    3.9.4 Advanced Accelerator Applications 2017 Business Region Distribution Analysis
    3.9.5 Advanced Accelerator Applications Nuclear Medicine/Radiopharmaceuticals Volume in Different Applications and Its Application Share
    3.10 IBA Molecular Imaging
    3.10.1 Company Basic Information, Manufacturing Base and Competitors
    3.10.2 Nuclear Medicine/Radiopharmaceuticals Product Category, Application and Specification
    3.10.2.1 Diagnostic (SPECT - Technetium, PET - F-18)
    3.10.2.2 Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90)
    3.10.3 IBA Molecular Imaging 2017 Nuclear Medicine/Radiopharmaceuticals Sales, Ex-factory Price, Revenue, Gross Margin Analysis
    3.10.4 IBA Molecular Imaging 2017 Business Region Distribution Analysis
    3.10.5 IBA Molecular Imaging Nuclear Medicine/Radiopharmaceuticals Volume in Different Applications and Its Application Share

    4 Technical Data and Manufacturing Plants Analysis of Nuclear Medicine/Radiopharmaceuticals
    4.1 Capacity and Commercial Production Date of Global Nuclear Medicine/Radiopharmaceuticals Major Manufacturers in 2017
    4.2 Manufacturing Plants Distribution of Global Nuclear Medicine/Radiopharmaceuticals Major Manufacturers in 2017
    4.4 R&D Status and Technology Source of Global Nuclear Medicine/Radiopharmaceuticals Major Manufacturers in 2017
    4.4 Raw Materials Sources Analysis of Global Nuclear Medicine/Radiopharmaceuticals Major Manufacturers in 2017

    5 Global Nuclear Medicine/Radiopharmaceuticals Overall Market Overview
    5.1 2012-2017 Overall Market Analysis
    5.2 Capacity Analysis
    5.2.1 2012-2017 Global Nuclear Medicine/Radiopharmaceuticals Capacity and Growth Rate Analysis
    5.2.2 2017 Nuclear Medicine/Radiopharmaceuticals Capacity Analysis (Company Segment)
    5.3 Sales Analysis
    5.3.1 2012-2017 Global Nuclear Medicine/Radiopharmaceuticals Sales and Growth Rate Analysis
    5.3.2 2017 Nuclear Medicine/Radiopharmaceuticals Sales Analysis (Company Segment)
    5.4 Sales Price Analysis
    5.4.1 2012-2017 Global Nuclear Medicine/Radiopharmaceuticals Sales Price
    5.4.2 2017 Nuclear Medicine/Radiopharmaceuticals Sales Price Analysis (Company Segment)

    6 Nuclear Medicine/Radiopharmaceuticals Regional Market Analysis
    6.1 North America Nuclear Medicine/Radiopharmaceuticals Market Analysis
    6.1.1 North America Nuclear Medicine/Radiopharmaceuticals Market Overview
    6.1.2 North America 2012-2017 Nuclear Medicine/Radiopharmaceuticals Local Supply, Import, Export, Local Consumption Analysis
    6.1.3 North America 2012-2017 Nuclear Medicine/Radiopharmaceuticals Sales Price Analysis
    6.1.4 North America 2017 Nuclear Medicine/Radiopharmaceuticals Market Share Analysis
    6.2 Europe Nuclear Medicine/Radiopharmaceuticals Market Analysis
    6.2.1 Europe Nuclear Medicine/Radiopharmaceuticals Market Overview
    6.2.2 Europe 2012-2017 Nuclear Medicine/Radiopharmaceuticals Local Supply, Import, Export, Local Consumption Analysis
    6.2.3 Europe 2012-2017 Nuclear Medicine/Radiopharmaceuticals Sales Price Analysis
    6.2.4 Europe 2017 Nuclear Medicine/Radiopharmaceuticals Market Share Analysis
    6.3 China Nuclear Medicine/Radiopharmaceuticals Market Analysis
    6.3.1 China Nuclear Medicine/Radiopharmaceuticals Market Overview
    6.3.2 China 2012-2017 Nuclear Medicine/Radiopharmaceuticals Local Supply, Import, Export, Local Consumption Analysis
    6.3.3 China 2012-2017 Nuclear Medicine/Radiopharmaceuticals Sales Price Analysis
    6.3.4 China 2017 Nuclear Medicine/Radiopharmaceuticals Market Share Analysis
    6.4 Japan Nuclear Medicine/Radiopharmaceuticals Market Analysis
    6.4.1 Japan Nuclear Medicine/Radiopharmaceuticals Market Overview
    6.4.2 Japan 2012-2017 Nuclear Medicine/Radiopharmaceuticals Local Supply, Import, Export, Local Consumption Analysis
    6.4.3 Japan 2012-2017 Nuclear Medicine/Radiopharmaceuticals Sales Price Analysis
    6.4.4 Japan 2017 Nuclear Medicine/Radiopharmaceuticals Market Share Analysis
    6.5 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Market Analysis
    6.5.1 Southeast Asia Nuclear Medicine/Radiopharmaceuticals Market Overview
    6.5.2 Southeast Asia 2012-2017 Nuclear Medicine/Radiopharmaceuticals Local Supply, Import, Export, Local Consumption Analysis
    6.5.3 Southeast Asia 2012-2017 Nuclear Medicine/Radiopharmaceuticals Sales Price Analysis
    6.5.4 Southeast Asia 2017 Nuclear Medicine/Radiopharmaceuticals Market Share Analysis
    6.6 India Nuclear Medicine/Radiopharmaceuticals Market Analysis
    6.6.1 India Nuclear Medicine/Radiopharmaceuticals Market Overview
    6.6.2 India 2012-2017 Nuclear Medicine/Radiopharmaceuticals Local Supply, Import, Export, Local Consumption Analysis
    6.6.3 India 2012-2017 Nuclear Medicine/Radiopharmaceuticals Sales Price Analysis
    6.6.4 India 2017 Nuclear Medicine/Radiopharmaceuticals Market Share Analysis

    7 Global 2012-2017 Nuclear Medicine/Radiopharmaceuticals Segment Market Analysis (by Type)
    7.1 Global 2012-2017 Nuclear Medicine/Radiopharmaceuticals Sales by Type
    7.2 Different Types of Nuclear Medicine/Radiopharmaceuticals Product Interview Price Analysis
    7.3 Different Types of Nuclear Medicine/Radiopharmaceuticals Product Driving Factors Analysis
    7.3.1 Diagnostic (SPECT - Technetium, PET - F-18) of Nuclear Medicine/Radiopharmaceuticals Growth Driving Factor Analysis
    7.3.2 Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90) of Nuclear Medicine/Radiopharmaceuticals Growth Driving Factor Analysis

    8 Global 2012-2017 Nuclear Medicine/Radiopharmaceuticals Segment Market Analysis (by Application)
    8.1 Global 2012-2017 Nuclear Medicine/Radiopharmaceuticals Consumption by Application
    8.2 Different Application of Nuclear Medicine/Radiopharmaceuticals Product Interview Price Analysis
    8.3 Different Application of Nuclear Medicine/Radiopharmaceuticals Product Driving Factors Analysis
    8.3.1 Oncology of Nuclear Medicine/Radiopharmaceuticals Growth Driving Factor Analysis
    8.3.2 Thyroid of Nuclear Medicine/Radiopharmaceuticals Growth Driving Factor Analysis
    8.3.3 Cardiology of Nuclear Medicine/Radiopharmaceuticals Growth Driving Factor Analysis

    9 Development Trend of Analysis of Nuclear Medicine/Radiopharmaceuticals Market
    9.1 Global Nuclear Medicine/Radiopharmaceuticals Market Trend Analysis
    9.1.1 Global 2018-2023 Nuclear Medicine/Radiopharmaceuticals Market Size (Volume and Value) Forecast
    9.1.2 Global 2018-2023 Nuclear Medicine/Radiopharmaceuticals Sales Price Forecast
    9.2 Nuclear Medicine/Radiopharmaceuticals Regional Market Trend
    9.2.1 North America 2018-2023 Nuclear Medicine/Radiopharmaceuticals Consumption Forecast
    9.2.2 Europe 2018-2023 Nuclear Medicine/Radiopharmaceuticals Consumption Forecast
    9.2.3 China 2018-2023 Nuclear Medicine/Radiopharmaceuticals Consumption Forecast
    9.2.4 Japan 2018-2023 Nuclear Medicine/Radiopharmaceuticals Consumption Forecast
    9.2.5 Southeast Asia 2018-2023 Nuclear Medicine/Radiopharmaceuticals Consumption Forecast
    9.2.6 India 2018-2023 Nuclear Medicine/Radiopharmaceuticals Consumption Forecast
    9.3 Nuclear Medicine/Radiopharmaceuticals Market Trend (Product Type)
    9.4 Nuclear Medicine/Radiopharmaceuticals Market Trend (Application)

    10 Marketing Strategy Analysis, Distributors/Traders
    10.1 Marketing Channel
    10.1.1 Direct Marketing
    10.1.2 Indirect Marketing
    10.1.3 Marketing Channel Development Trend
    10.2 Market Positioning
    10.2.1 Pricing Strategy
    10.2.2 Brand Strategy
    10.2.3 Target Client
    10.3 Distributors/Traders List

    11 Nuclear Medicine/Radiopharmaceuticals Marketing Type Analysis
    11.1 Nuclear Medicine/Radiopharmaceuticals Regional Marketing Type Analysis
    11.2 Nuclear Medicine/Radiopharmaceuticals International Trade Type Analysis
    11.3 Traders or Distributors with Contact Information of Nuclear Medicine/Radiopharmaceuticals by Region
    11.4 Nuclear Medicine/Radiopharmaceuticals Supply Chain Analysis

    12 Consumers Analysis of Nuclear Medicine/Radiopharmaceuticals
    12.1 Consumer 1 Analysis
    12.2 Consumer 2 Analysis
    12.3 Consumer 3 Analysis
    12.4 Consumer 4 Analysis

    13 Conclusion of the Global Nuclear Medicine/Radiopharmaceuticals Market Professional Survey Report 2018

    14 Methodology and Data Source
    14.1 Methodology/Research Approach
    14.1.1 Research Programs/Design
    14.1.2 Market Size Estimation
    14.1.3 Market Breakdown and Data Triangulation
    14.2 Data Source
    14.2.1 Secondary Sources
    14.2.2 Primary Sources
    14.3 Disclaimer
    14.4 Author List

  • Pre-sales Enquiry

    The free sample report is clearly a representation of the complete report. Buy report to get the complete market scope/data depth information.

Related Products
$2980 - $5960 - $5960
Publisher : 99Strategy Publication Date : Jun 20, 2018

Number of Pages : 77 Subcategory : Pharmaceuticals
$2980 - $5960 - $5960
Publisher : 99Strategy Publication Date : Jun 20, 2018

Number of Pages : 89 Subcategory : Pharmaceuticals
$2980 - $5960 - $5960
Publisher : 99Strategy Publication Date : Jun 21, 2018

Number of Pages : 91 Subcategory : Pharmaceuticals
$2980 - $5960 - $5960
Publisher : 99Strategy Publication Date : Jun 20, 2018

Number of Pages : 90 Subcategory : Pharmaceuticals